1. Home
  2. ACON vs PMCB Comparison

ACON vs PMCB Comparison

Compare ACON & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$2.35

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.55

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACON
PMCB
Founded
2008
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
6.3M
IPO Year
2022
2001

Fundamental Metrics

Financial Performance
Metric
ACON
PMCB
Price
$2.35
$0.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
41.1K
125.6K
Earning Date
05-15-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
99.82
N/A
EPS
N/A
N/A
Revenue
$75,730.00
N/A
Revenue This Year
$87.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
65.62
N/A
52 Week Low
$1.95
$0.53
52 Week High
$12.03
$1.51

Technical Indicators

Market Signals
Indicator
ACON
PMCB
Relative Strength Index (RSI) 43.43 35.67
Support Level $1.95 $0.55
Resistance Level $2.50 $0.77
Average True Range (ATR) 0.18 0.04
MACD 0.03 0.00
Stochastic Oscillator 72.73 31.02

Price Performance

Historical Comparison
ACON
PMCB

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: